WeVote
Log In

Bill

Bill

HB 1211

Insurance; guidelines and recommendations for colorectal cancer screening, examinations, and laboratory tests; provide

2025-2026 Regular Session Introduced by Demetrius Douglas and 5 co-sponsors

Georgia mandates insurance coverage of colorectal cancer screening and related tests per clinical guidelines, removing cost barriers to increase early detection and preventive care access.

Senate Read Second Time
#health #insurance
0
WeVote Research Nonpartisan
Bill Summary · HB 1211

Legislative bill overview

HB 1211 requires insurance companies in Georgia to cover colorectal cancer screening, examinations, and related laboratory tests according to established clinical guidelines and recommendations. The bill essentially mandates insurance coverage for preventive colorectal cancer services without cost-sharing barriers for eligible individuals.

Why is this important

Colorectal cancer is the second-leading cause of cancer death in the U.S., yet screening rates remain suboptimal, particularly among lower-income populations. Removing financial barriers through insurance coverage directly increases screening rates, enabling earlier detection when treatment is most effective and least expensive. This addresses both individual health outcomes and broader public health priorities.

Potential points of contention

  • Insurer cost concerns: Insurance companies may argue the mandate increases premiums for all policyholders by expanding covered services, though preventive care typically reduces long-term costs
  • Definition of "guidelines and recommendations": Ambiguity about which specific clinical guidelines apply (USPSTF, ACS, AGA) could create implementation disputes between insurers and providers
  • Scope limitations: The bill may not address coverage for screening in uninsured populations, limiting its reach among highest-risk groups with lowest current screening rates

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.